Clinical trials
Phase 1/2 Rhabdomyosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 9 |
| Terminated | 4 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Eisai Inc. | 2 |
| St. Jude Children's Research Hospital | 2 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| David S Shulman, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 35 |
| Sarcoma, Ewing | 17 |
| Neuroblastoma | 14 |
| Osteosarcoma | 14 |
| Sarcoma | 14 |
| Neuroectodermal Tumors, Primitive, Peripheral | 7 |
| Sarcoma, Synovial | 6 |
| Liposarcoma | 5 |
| Neoplasms | 5 |
| Recurrence | 5 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.